Justin Chakma, Chief Business Officer at ARS Pharmaceuticals, Inc. (SPRY), sold 142,186 shares at $14.00 ($2.0M) on 2024-11-25, disclosed to the SEC on 2024-11-27.
Open-market sale of $2.0M SPRY by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.00 | 32,814 | $459K | 22.9% |
| 2 | $14.05 | 42,186 | $593K | 29.6% |
| 3 | $14.05 | 42,186 | $593K | 29.6% |
| 4 | $14.39 | 25,000 | $360K | 17.9% |
| Total | $14.10 avg | 142,186 | $2.0M | 100% |
| Filing → |
| SPRY | SELL | 2024-12-12 | $658K | — | Filing → |
| SPRY | SELL | 2024-12-06 | $2.7M | — | Filing → |
| SPRY | SELL | 2024-12-04 | $1.2M | — | Filing → |